Learn when to sell franchise locations by evaluating financial performance, operations, market conditions, lease terms, and long-term business goals carefully.
Jul 20, 2026
Wingstop adds 382 U.S. units to 3,056 total as comps dip; 2026 outlook hinges on loyalty, Smart Kitchen, and category tailwinds.
Jul 20, 2026
Topgolf Media Networks turns 100+ venues into an ad platform with 42M visits and 28,000 screens, tapping retail media tactics for measurable brand activations.
Jul 20, 2026
Discover how Fresh off the Boat in Santa Ana has built a thriving, health-focused Mexican-Mediterranean fusion restaurant. Explore operational insights, business strategies, and the customer experience that set this unique concept apart.
Jul 20, 2026
If your restaurant is busy but profits feel thin, food cost is usually the first place to look. Not because it is always the problem, but because it is the most controllable variable in your P&L.
Jul 20, 2026
Burger King launches its “Your Way Champion” managerial role, focusing on guest experience, order customization, and staff engagement. Restaurant operators can glean insights for elevating hospitality in their own venues.
Jul 20, 2026
Domino’s leverages rising order volumes to boost revenue and market share despite industry challenges in Q2 2026, offering key lessons for restaurant owners.
Jul 20, 2026
Thomas Keller Restaurant Group will pay $2M to settle an EEOC harassment and retaliation case tied to Bouchon Las Vegas, closing a long-running action from 2018.
Jul 19, 2026
Fresh Kitchen names Bill Knopf and Matt Livingston to lead operations and development as the clean-label bowl brand targets growth beyond 100 locations.
Jul 18, 2026
Hardee’s franchisee Superior Star filed Chapter 11 after a 2023 deal revealed unpaid taxes, costly repairs, and lease burdens; plans to reject leases and refocus.
Jul 18, 2026
Explore the use of poison pills as a strategic defense mechanism against activist investors and how they impact shareholder value and corporate strategies.
Photo by Ehimetalor Akhere Unuabona
Photo by Ehimetalor Akhere Unuabona
Poison pills, also known as shareholder rights plans, have evolved over the years from being a preventative measure to a reactive strategy in response to specific threats like hostile takeovers by activist investors. In the past, during the 1990s, many Fortune 100 companies routinely adopted poison pills as a proactive defense mechanism. These pills were designed to dilute the holdings of an acquiring entity once it bought a certain threshold of shares, making takeovers more expensive and challenging.
Photo by Ehimetalor Akhere Unuabona
In the contemporary corporate landscape, poison pills are more tailored and situation-specific. Companies are strategically using them to combat activist investors like Biglari Capital. By setting specific triggers and durations, boards can respond swiftly to perceived threats without committing to prolonged defensive measures. Limited-duration pills are now prevalent, with many lasting less than a year, offering flexibility to boards.
Photo by Ehimetalor Akhere Unuabona
While poison pills are often criticized as anti-shareholder tactics, they serve as a crucial tool for boards to maximize shareholder value. Keith Gottfried, a seasoned advisor on poison pills, emphasizes that these strategies do not hinder legitimate acquisition offers but rather prevent hostile takeovers that undervalue the company. By giving boards time to enact strategic plans or consider better offers, poison pills safeguard shareholder interests and corporate growth.
Photo by Ehimetalor Akhere Unuabona
Activist investors may challenge poison pills in court, but success is rare, especially when the threshold to trigger the pill is reasonable. Delaware courts have historically upheld the legality of poison pills, assuming boards act in good faith to protect shareholders. Long-term pills, requiring shareholder approval, face resistance from institutional investors and proxy firms due to their perceived hindrance to potential deals.
Photo by Ehimetalor Akhere Unuabona
The prevalence of activist investors in the market necessitates companies, especially in the restaurant sector like Jack in the Box, to consider having poison pills readily available as a defense mechanism. While not universally welcomed, these tools offer essential protection in an increasingly volatile market, allowing boards to navigate challenges and prioritize sustainable corporate growth.
